Vanguard Group’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $165M | Buy |
9,706,224
+834,932
| +9% | +$14.2M | ﹤0.01% | 1601 |
|
|
2025
Q1 | $173M | Buy |
8,871,292
+1,249,303
| +16% | +$24.4M | ﹤0.01% | 1544 |
|
|
2024
Q4 | $189M | Sell |
7,621,989
-222,617
| -3% | -$5.52M | ﹤0.01% | 1568 |
|
|
2024
Q3 | $192M | Sell |
7,844,606
-55,773
| -0.7% | -$1.37M | ﹤0.01% | 1561 |
|
|
2024
Q2 | $185M | Buy |
7,900,379
+321,611
| +4% | +$7.54M | ﹤0.01% | 1529 |
|
|
2024
Q1 | $250M | Buy |
7,578,768
+413,892
| +6% | +$13.7M | 0.01% | 1375 |
|
|
2023
Q4 | $195M | Buy |
7,164,876
+349,906
| +5% | +$9.52M | ﹤0.01% | 1517 |
|
|
2023
Q3 | $164M | Sell |
6,814,970
-195,009
| -3% | -$4.69M | ﹤0.01% | 1539 |
|
|
2023
Q2 | $224M | Buy |
7,009,979
+624,488
| +10% | +$19.9M | 0.01% | 1420 |
|
|
2023
Q1 | $196M | Buy |
6,385,491
+111,861
| +2% | +$3.43M | 0.01% | 1466 |
|
|
2022
Q4 | $245M | Buy |
6,273,630
+99,159
| +2% | +$3.88M | 0.01% | 1325 |
|
|
2022
Q3 | $294M | Buy |
6,174,471
+927,970
| +18% | +$44.2M | 0.01% | 1147 |
|
|
2022
Q2 | $203M | Buy |
5,246,501
+534,491
| +11% | +$20.7M | 0.01% | 1416 |
|
|
2022
Q1 | $270M | Buy |
4,712,010
+14,745
| +0.3% | +$845K | 0.01% | 1352 |
|
|
2021
Q4 | $374M | Buy |
4,697,265
+180,565
| +4% | +$14.4M | 0.01% | 1182 |
|
|
2021
Q3 | $393M | Buy |
4,516,700
+1,081,128
| +31% | +$94.1M | 0.01% | 1132 |
|
|
2021
Q2 | $442M | Buy |
3,435,572
+202,162
| +6% | +$26M | 0.01% | 1070 |
|
|
2021
Q1 | $259M | Buy |
3,233,410
+417,780
| +15% | +$33.4M | 0.01% | 1433 |
|
|
2020
Q4 | $230M | Buy |
2,815,630
+567,257
| +25% | +$46.3M | 0.01% | 1391 |
|
|
2020
Q3 | $55.4M | Buy |
2,248,373
+1,082,753
| +93% | +$26.7M | ﹤0.01% | 1967 |
|
|
2020
Q2 | $32.6M | Buy |
1,165,620
+1,071,678
| +1,141% | +$30M | ﹤0.01% | 2205 |
|
|
2020
Q1 | $1.69M | Buy |
+93,942
| New | +$1.69M | ﹤0.01% | 3349 |
|